SCHEMBL13699792

SCHEMBL13699792

NC(=O)c1oc2ccc(Cl)cc2c1NC(=O)c1ccc2c(c1)CCC2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.60
ALDH1A1 P00352 5/20 0.48
HPGD P15428 5/20 0.48
HSD17B10 Q99714 4/20 0.48
MAPK10 P53779 4/20 0.47
MAPT P10636 4/20 0.47
TP53 P04637 3/20 0.47
TSHR P16473 2/20 0.47
AHR P35869 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
MAPK1 P28482 2/20 0.46
NPSR1 Q6W5P4 1/20 0.44
GAA P10253 1/20 0.43
POLB P06746 1/20 0.43
RAD52 P43351 1/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
LMNA P02545 2/20 0.43
NPC1 O15118 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699788 0.85 KDM4E (0.57) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699710 0.82 KDM4E (0.67) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699692 0.81 TP53 (0.70) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699724 0.81 KDM4E (0.70) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699784 0.81 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10MAPT
SCHEMBL4251178 0.81 ALDH1A1 (0.72) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699803 0.80 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699739 0.79 KDM4E (0.63) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699728 0.78 KDM4E (0.65) KDM4EALDH1A1HPGDHSD17B10MAPK10
SCHEMBL13699807 0.78 KDM4E (0.65) KDM4EALDH1A1HPGDHSD17B10MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885ALDH1A1 559/4885HPGD 3251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.